Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | RAD52 | P43351 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | LIG1 | P18858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21756960 | 0.90 | MEN1 (0.44) | LMNAALDH1A1MEN1KMT2ARAD52 | |
| SCHEMBL25709655 | 0.90 | LMNA (0.63) | LMNAALDH1A1MEN1KMT2ARAD52 | |
| SCHEMBL25709691 | 0.90 | LMNA (0.63) | LMNAALDH1A1MEN1KMT2ARAD52 | |
| SCHEMBL2709413 | 0.90 | LMNA (0.63) | LMNAALDH1A1MEN1KMT2ARAD52 | |
| SCHEMBL7104226 | 0.88 | LMNA (0.49) | LMNAALDH1A1MEN1KMT2ARAD52 | |
| SCHEMBL21382098 | 0.85 | MEN1 (0.51) | LMNAALDH1A1MEN1KMT2ARAD52 | |
| SCHEMBL22815523 | 0.84 | ALDH1A1 (0.57) | LMNAALDH1A1MEN1KMT2ARAD52 | |
| SCHEMBL25907689 | 0.84 | ALDH1A1 (0.57) | LMNAALDH1A1MEN1KMT2ARAD52 | |
| SCHEMBL27383409 | 0.84 | ALDH1A1 (0.57) | LMNAALDH1A1MEN1KMT2ARAD52 | |
| SCHEMBL25709677 | 0.84 | ALDH1A1 (0.57) | LMNAALDH1A1MEN1KMT2ARAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301182-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-09-21 | — | — | US | disclosed |
| WO-2023096209-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2023-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230301182-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | OR10J3, ESR1, EPCAM | LMNA 3840/4885ALDH1A1 496/4885MEN1 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.